Chando Soothing Moisturizing Emulsion
Everything behind the verdicts on this product: the rule that fired for each concern, the three answers and the documents they rest on, every study on the row with the date it was opened, and the versions of the tables that produced them. Nothing here is edited by hand; it is generated from the same records the verdicts are.
The scaleRecommendedGoodSupportingEarly evidenceNot for thisAvoidhow it works
Engine 5.2.0 · rules 0.5.1 · evidence table ev-2026.10-r231 · computed October 13, 2026 · how we decide · the evidence table · the anchors
for Dehydration
Panthenol (Vitamin B5) is a reference standard by mechanism for dehydration; this emulsion carries it.
A trial-supported active, or a reference standard by mechanism, at a working level; or a first-line active below its studied range.
- Rule
- R5 → Good choice. A supported active (trial-backed, or a reference standard by mechanism); declared at a working strength, or a labelled active or at a plausible but undeclared level.
q1 = supported · q2 = adequate | plausible
Why this rule exists: Trial-supported or guideline-supported active, adequately or plausibly dosed.
Rule R5 decided 9,843 verdicts across the catalog; “Good choice” is the verdict on 10,340 of 45,446. The full register. - Carrying active
- Panthenol
- 1 · Standing
- Supported — its mechanism is established (a reference standard, not a trial result)
- 2 · Form
- Plausible — concentration not declared; read from the position in the ingredient list
Studied range: 2.5%, from the trials on the row; needs leave-on contact - 3 · Tolerability
- Standard tolerability
- Evidence dots
- Limited evidence
Row checked against its sources on July 17, 2026 (evidence table ev-2026.10-r231). - What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- September 25, 2026 (unchanged across rebuilds since then)
The studies and documents on the row
- Cosmetic Ingredient Review assessment of panthenol / dexpanthenol — humectant and moisturizer that raises stratum-corneum water content — reference work
← Back to the verdict All dehydration products → Disclose a concentration or correct a fact →
for Sensitivity
This formula carries fragrance — the kind of thing reactive skin flags first.
The formula carries a known trigger for the concern — fragrance for rosacea, comedogenic esters for acne, fungal triggers for fungal acne — which decides the verdict before any efficacy question.
- Rule
- F1 → Avoid. The formula carries a known trigger for the concern.
q3 = harsh
Why this rule exists: Sensitivity has no efficacy claim; the verdict is tolerability.
Rule F1 decided 605 verdicts across the catalog; “Avoid” is the verdict on 1,912 of 45,446. The full register. - Carrying active
- Centella Asiatica Extract
- 1 · Standing
- None
- 2 · Form
- Plausible — concentration not declared; read from the position in the ingredient list
Studied range: 0.05%, from the trials on the row; needs leave-on contact - 3 · Tolerability
- Carries a trigger — fragrance load
- Evidence dots
- Not from a trial row
- What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- September 25, 2026 (unchanged across rebuilds since then)
The studies and documents on the row
- The Effectiveness and Safety of a Skin Care Product With Centella asiatica Leaf Extract, Ceramide NP, and Panthenol in Subjects With Sensitive Skin: A Prospective, Observational Study — Journal of Cosmetic Dermatology (2025), opened July 16, 2026
- The Effects of a Standardized Extract of Centella asiatica on Postlaser Resurfacing Wound Healing on the Face: A Split-Face, Double-Blind, Randomized, Placebo-Controlled Trial — Journal of Alternative and Complementary Medicine (2020), opened July 16, 2026
← Back to the verdict All sensitivity products → Disclose a concentration or correct a fact →
for Compromised Skin Barrier
This formula carries fragrance — a known trigger for compromised skin barrier — so it is not a fit however good its actives are.
The formula carries a known trigger for the concern — fragrance for rosacea, comedogenic esters for acne, fungal triggers for fungal acne — which decides the verdict before any efficacy question.
- Rule
- R1 → Avoid. The formula carries a known trigger for the concern.
q3 = harsh
Why this rule exists: Safety outranks praise (MASTER-PLAN §1.7). A condition-weighted trigger (multiplier ≥ 2 in condition-fit-matrix) decides the verdict before any efficacy question.
Rule R1 decided 1,307 verdicts across the catalog; “Avoid” is the verdict on 1,912 of 45,446. The full register. - Carrying active
- Niacinamide
- 1 · Standing
- Supported — its mechanism is established (a reference standard, not a trial result)
- 2 · Form
- Adequate — concentration not declared; read from the position in the ingredient list
Studied range: 2%, from the trials on the row; needs leave-on contact; judge it after about 8 weeks - 3 · Tolerability
- Carries a trigger — fragrance load
- Evidence dots
- Limited evidence
Row checked against its sources on July 17, 2026 (evidence table ev-2026.10-r231). - What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- September 25, 2026 (unchanged across rebuilds since then)
The studies and documents on the row
- Moisturizing effects of topical nicotinamide on atopic dry skin — International Journal of Dermatology (2005), opened July 16, 2026
- Two randomized, controlled, comparative studies of the stratum corneum integrity benefits of two cosmetic niacinamide/glycerin body moisturizers vs. conventional body moisturizers — Journal of Drugs in Dermatology (2012), opened July 16, 2026
- Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea — Cutis (2005), opened July 16, 2026
- Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier — British Journal of Dermatology (2000), opened July 16, 2026
← Back to the verdict All compromised skin barrier products → Disclose a concentration or correct a fact →
for Dryness
Hyaluronic Acid is a reference standard by mechanism for dryness; this emulsion carries it.
A trial-supported active, or a reference standard by mechanism, at a working level; or a first-line active below its studied range.
- Rule
- R5 → Good choice. A supported active (trial-backed, or a reference standard by mechanism); declared at a working strength, or a labelled active or at a plausible but undeclared level.
q1 = supported · q2 = adequate | plausible
Why this rule exists: Trial-supported or guideline-supported active, adequately or plausibly dosed.
Rule R5 decided 9,843 verdicts across the catalog; “Good choice” is the verdict on 10,340 of 45,446. The full register. - Carrying active
- Sodium Hyaluronate
- 1 · Standing
- Supported — its mechanism is established (a reference standard, not a trial result)
- 2 · Form
- Plausible — concentration not declared; read from the position in the ingredient list
- 3 · Tolerability
- Standard tolerability — fragrance load
Cautions: fragrance. - Evidence dots
- Limited evidence
- What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- October 13, 2026
The studies and documents on the row
- Effectiveness of topical hyaluronic acid of different molecular weights in xerosis cutis treatment in elderly: a double-blind, randomized controlled trial. — Archives of Dermatological Research (Springer) — 36 nursing-home residents aged 60-80, Universitas Indonesia / Cipto Mangunkusumo Hospital; investigator-initiated, no manufacturer authorship on the author list; registered NCT06178367. JOURNAL NOT IN source-tiers.json — recorded conservatively as tier 3 pending an operator registry decision (it is a PubMed-indexed specialty dermatology journal, arguably tier 2). (2024), opened October 13, 2026
- Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. — International Journal of Toxicology — Cosmetic Ingredient Review Expert Panel (industry-funded review body). Establishes the declared cosmetic FUNCTION (skin-conditioning agent, used up to 2%); it is a safety assessment and makes no efficacy finding for dryness. (2009), opened October 13, 2026
← Back to the verdict All dryness products → Disclose a concentration or correct a fact →
as a moisturizer
Does what a moisturizer is for: draws in water, seals moisture in.
- Rule
- J2 → Does the job. The category-job reading is 65 or more.
Category job score over the measured features 65–85. - Measured from the label
- draws in water, softens and smooths, seals moisture in, supplies barrier lipids, right weight for the job
- Tolerability
- Standard tolerability
- Fragrance
A verdict is Dermington’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Every rule is public and the same for every product; a brand cannot buy a reading. How we decide · what has changed · disclaimer.